Genomics and Models of Nerve Sheath Tumors
Hirbe, Angela C.
Genomics and Models of Nerve Sheath Tumors - Basel, Switzerland MDPI - Multidisciplinary Digital Publishing Institute 2020 - 1 electronic resource (172 p.)
Open Access
Nerve sheath tumors can be a significant cause of morbidity for many patients. These include benign tumors such as schwannomas, diffuse and plexiform neurofibromas, and atypical neurofibromas, as well as the aggressive soft tissue sarcoma known as the malignant peripheral nerve sheath tumor (MPNST). Nerve sheath tumors occur sporadically and in the context of the clinical neuro-genetic tumor predisposition syndromes neurofibromatosis type 1 (NF1) and type 2 (NF2). Historically, the mainstay of treatment for nerve sheath tumors has been surgery. However, for both benign and malignant nerve sheath tumors, there is a high recurrence rate, highlighting the pressing need for novel therapies. As we have entered the genomic era, the hope is that an improved understanding of the genetics, and therefore the biology, of these tumors will ultimately lead to therapies that result in better outcomes. In this Special Issue, we include both review articles and original research related to the genomic understanding and modeling of schwannomas, plexiform and diffuse neurofibromas, atypical neurofibromas, and malignant peripheral nerve sheath tumors as well as genomic methods being developed and applied to advance our understanding of these tumors.
Creative Commons
English
books978-3-03943-490-9 9783039434893 9783039434909
10.3390/books978-3-03943-490-9 doi
Medicine
neurofibromatosis type 1 nerve sheath tumor cancer latent variables machine learning supervised learning transfer learning random forest metaVIPER tumor deconvolution neurofibromatosis malignant peripheral nerve sheath tumor MPNST polycomb repressive complex PRC2 NF1 kinase kinome adaptation kinome reprogramming MET MEK doxorubicin capmatinib tram genomics tumor evolution pathology next generation sequencing clinical genetics malignant peripheral nerve sheath tumors plexiform neurofibromas Schwann cells neurofibromatosis type 1 syndrome neurofibromin 1 genetically engineered mouse models heterogeneity CRISPR/Cas9 mouse models sarcoma tumor microenvironment neurofibromatosis 1 (NF1) mebendazole (MBZ) COX-2 inhibitor malignancy chemoprevention nerve sheath tumors
Genomics and Models of Nerve Sheath Tumors - Basel, Switzerland MDPI - Multidisciplinary Digital Publishing Institute 2020 - 1 electronic resource (172 p.)
Open Access
Nerve sheath tumors can be a significant cause of morbidity for many patients. These include benign tumors such as schwannomas, diffuse and plexiform neurofibromas, and atypical neurofibromas, as well as the aggressive soft tissue sarcoma known as the malignant peripheral nerve sheath tumor (MPNST). Nerve sheath tumors occur sporadically and in the context of the clinical neuro-genetic tumor predisposition syndromes neurofibromatosis type 1 (NF1) and type 2 (NF2). Historically, the mainstay of treatment for nerve sheath tumors has been surgery. However, for both benign and malignant nerve sheath tumors, there is a high recurrence rate, highlighting the pressing need for novel therapies. As we have entered the genomic era, the hope is that an improved understanding of the genetics, and therefore the biology, of these tumors will ultimately lead to therapies that result in better outcomes. In this Special Issue, we include both review articles and original research related to the genomic understanding and modeling of schwannomas, plexiform and diffuse neurofibromas, atypical neurofibromas, and malignant peripheral nerve sheath tumors as well as genomic methods being developed and applied to advance our understanding of these tumors.
Creative Commons
English
books978-3-03943-490-9 9783039434893 9783039434909
10.3390/books978-3-03943-490-9 doi
Medicine
neurofibromatosis type 1 nerve sheath tumor cancer latent variables machine learning supervised learning transfer learning random forest metaVIPER tumor deconvolution neurofibromatosis malignant peripheral nerve sheath tumor MPNST polycomb repressive complex PRC2 NF1 kinase kinome adaptation kinome reprogramming MET MEK doxorubicin capmatinib tram genomics tumor evolution pathology next generation sequencing clinical genetics malignant peripheral nerve sheath tumors plexiform neurofibromas Schwann cells neurofibromatosis type 1 syndrome neurofibromin 1 genetically engineered mouse models heterogeneity CRISPR/Cas9 mouse models sarcoma tumor microenvironment neurofibromatosis 1 (NF1) mebendazole (MBZ) COX-2 inhibitor malignancy chemoprevention nerve sheath tumors